Therefore, in everyday clinical practice, and especially when practicing in countries where resources are limited, our study indicates that prediction value in high-risk early breast cancer patients, especially in Luminal A and Luminal B subtypes, HER2-negative patients and those with >3 positive nodes, significantly improves with the combination of three rather easy to perform scores. Here, ERBB2 is linked to breast carcinoma.